Irreversible Electroporation Solutions
Unlocking the Power of Irreversible Electroporation
Irreversible electroporation (IRE) is revolutionizing the way clinicians approach hard-to-treat tumors. Utilizing high voltage electrical pulses, irreversible electroporation technology offers a non-thermal, tissue-selective ablation method that preserves critical structures while creating desirable therapeutic lesions.
At Vantage MedTech, we help electroporation device innovators to bring their next-generation platforms to life. With over 30 years of experience engineering custom energy-based devices, our AdvantageIRE™ platform provides a flexible, fully customizable foundation for rapid prototyping, waveform exploration, and first-in-human system development. The platform offers a preclinical system configurable for early-stage innovation and discovery alongside clinical use reference designs which are leveraged to accelerate product development.
From concept to clinic, Vantage MedTech is your partner to bring your irreversible electroporation device to market to treat cancer patients.
Why Vantage MedTech?
Customizable Electroporation Machine Architecture
Build with confidence on a scalable, field-proven platform. AdvantageIRE™ supports voltages exceeding 5kV, along with fully tunable parameters including pulse width, frequency, pulse patterns, cardiac synchronization, and mono-phasic or bi-phasic delivery configurations. We design medical devices to meet the nuanced demands of modern pulsed field ablation systems.Real-Time Waveform Testing
Fine-tune waveform parameters using an intuitive user interface. During preclinical development, engineers and researchers can rapidly iterate on pulse characteristics and electroporation probe configurations, shortening the path to optimal performance and safety.Accelerated Path to First-in-Human (FIH)
Leverage your benchtop findings directly into a clinical-grade platform. Vantage’s flexible system architecture makes it easy to transition from waveform testing to a fully customized electroporation instrument that’s ready for regulatory submission and FIH studies.Leasable Development Platform
AdvantageIRE™ is available as a leasable, configurable electroporation device development system, enabling your team to test and validate concepts without the risk, time, or expense of building from scratch.Built for Innovation, Backed by Expertise
Proven Track Record in Pulsed Field Systems
Our engineering teams have decades of experience developing RF, microwave, and pulsed energy devices across cardiology, oncology, neurology, and beyond.In-House Integration Across the Stack
From hardware to software to embedded firmware, all development is handled under one roof. We give you tighter control over timelines, cost, and quality without cutting corners.FDA-Level Compliance Standards
Whether you’re building a clinical trial system or a commercial electroporation device, we embed usability, cybersecurity, and regulatory foresight into every step of the design process.Our Suite of Electroporation Development Tools
Advantage™ Connect
Keep your electroporation machine connected and updated with secure over-the-air software refreshes, log access, and GUI upgrades, ideal for ongoing development or postmarket support.Advantage™ UI
Develop your system around a validated, highly usable graphical interface that’s already been optimized for clinical workflows. Customize it to match your users’ needs, from surgeons to electrophysiologists.Impart™ Smart Chip Technology
Protect your electroporation device consumables with our patented Impart™ technology. Lock out counterfeit components and enable secure reuse control with integrated chip-level authentication.How AdvantageIRE™ Powers Product Development
From benchtop to bedside, here’s how our platform supports your product lifecycle:
- Prototype: Lease our electroporation platform to test concepts, tune waveforms, and refine energy delivery models.
- Customize: Adapt the core system into a fully branded, clinical-ready electroporation device.
- Validate: Partner with our regulatory and quality experts to prepare for FIH studies and commercial launch.
- Scale: Vantage supports scalable pathways to volume production so you can manufacture with confidence.
Designed for Compliance, Built for Speed
Healthcare device development doesn’t stop at proof of concept. With Vantage MedTech, compliance is built into the architecture, not added on later. We design every electroporation instrument to align with FDA, IEC 60601, and ISO 14971 standards, ensuring safety, reliability, and usability from day one.
Our in-house regulatory and quality experts partner with your team to navigate pre-submission meetings, design controls, risk management, and clinical trial preparation, all while keeping your timeline on track.
Applications Across Electroporation Use Cases
Our electroporation platform adapts to your goals, from pulsed field ablation for atrial fibrillation to exploring oncology-specific tissue ablation.
- Cardiac Ablation (PFA): Deliver non-thermal pulsed field ablation for pulmonary vein isolation and atrial fibrillation treatment with high precision and cardiac sync integration.
- Oncology: Target cancerous tissue while sparing surrounding nerves and vessels, ideal for pancreas, liver, and prostate tumors.
- Electroporation Research: Customize pulsing strategies, probe geometries, and energy profiles in real time during preclinical research.
- Electroporation Machine OEMs: Reduce development risk and time-to-market with a plug-and-play design foundation.
Why Choose Our Irreversible Electroporation Development Platform?
Explore our platform designs to attain capabilities surpassing 5kV, alongside adjustable pulse width settings, pulsing patterns, cardiac sync integration, and other cutting-edge irreversible electroporation design solutions.
Rapidly change your IRE waveforms parameters on an easy-to-use UI for real time configuration during pre-clinical development. Determining optimal waveform parameters provides a head start on your irreversible electroporation development project.
Take your pre-clinical IRE waveform findings into your first in human system. Leverage irreversible electroporation engineering platform designs to accelerate first in human system product development.
Your Innovation, Our Platform
We designed AdvantageIRE™ to be more than a development tool — it’s a springboard for electroporation breakthroughs. With years of experience manufacturing electroporation instruments Vantage MedTech supports you every step of the way: from idea to impact.
Let’s bring your irreversible electroporation system to life with confidence, compliance, and clarity.
Rely on partners who can tailor their approach to your specific needs, regardless of where you are in your medical device journey.
Our extensive expertise in clinical segments, particularly in irreversible electroporation engineering is bolstered by our experienced team, streamlined processes, specialized portfolio, and proprietary platforms.
Minimize execution risk by partnering with a medical device software company with a track record of successfully developing over 1,600 medical devices.
Leverage our proprietary platform architecture and shorten time-to-market timelines by up to 60%.
Our in-house team of specialized engineers will bring your IRE project from concept to reality with expert care and execution.